https://psychedelicalpha.com/news/magicmed-to-be-acquired-by-nasdaq-listed-company
Read More
Enveric Biosciences Buys MagicMed In All Stock Deal Valued At $30 Million [The Green Market Journal]
https://www.greenmarketreport.com/enveric-biosciences-buys-magicmed-in-all-stock-deal-valued-at-30-million/
Read More
https://psychedelicinvest.com/finding-the-derivative-with-dr-joseph-tucker/
Read More
https://psychedelicspotlight.com/enveric-biosciences-acquires-magicmed-industries/
Read More
https://truffle.report/nasdaqenvb-enveric-moves-to-acquire-magicmed-form-latest-nasdaq-listed-psychedelics-company/
Read More
https://www.marijuanamag.net/enveric-biosciences-buys-magicmed-in-all-stock-deal-valued-at-30-million/
Read More
NAPLES, Fla., May 18, 2021 — Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid (CBD) medicines to improve quality of life for cancer patients,…
Read More
Cedars-Sinai Veteran Physician Joins Four Additional Clinical, Oncology and Cannabinoid Experts to Guide the Company’s Research and Scientific Programs NAPLES, Fla., May 12, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a…
Read More
NAPLES, FL / April 14, 2021 / Enveric Biosciences (NASDAQ:ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today…
Read More
https://www.cancernetwork.com/view/oncology-peer-review-on-the-go-1-on-1-with-david-johnson-enveric-s-endocannabinoid-products-for-glioblastoma
Read More
